Rua Bioscience Limited logo

Update regarding manufacturing facility sales contract

Operational Update21 October 2024RUAHealthcare

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com




FOR PUBLIC RELEASE

NZX Limited

Wellington


22

nd

October 2024



Update: Unconditional sales contract of Rua manufacturing facility


At the time of the release of the Rua Bioscience FY24 Annual Report on 1 October, 2024

the Directors had accommodated a payment date deferral for the deposit to allow the

purchaser (Awa Ora Genesis Kaitiaki Harakeke Trust of Te Araroa) to more explicitly

secure land ownership rights once the lease has been transferred.


At the time of this announcement, land ownership rights have now been explicitly

secured, however Rua has not yet received the 10% deposit that is due under the

contract.


Rua is in regular communication with the purchaser and they have confirmed that full

settlement is expected as contractually agreed on 30 October, 2024.



ENDS  



The person who authorised this announcement:


Paul Naske

Chief Executive Officer

paul.naske@ruabio.com

+64 21 445154




MARKET UPDATE

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.